Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Aprea Therapeutics Inc (APRE)

5.45   -0.32 (-5.55%) 03-05 09:20
Open: 5.75 Pre. Close: 5.77
High: 5.79 Low: 5.2
Volume: 955,384 Market Cap: 115M
Aprea Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The company is headquartered in Boston, Massachusetts and currently employs 14 full-time employees. The firm is focused on developing and commercializing cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Its lead product candidate, APR-246, is a small molecule p53 reactivator that is being developed for hematologic malignancies, including myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). APR-246 product candidate is designed to be administered intravenously and forms the active moiety, 2-methylene-quinuclidin-3-one (MQ), under physiological conditions. Its second product candidate, APR-548, is a p53 reactivator. APR-548 is being developed in an oral dosage form.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 5.799 - 5.839 5.839 - 5.87
Low: 5.102 - 5.153 5.153 - 5.192
Close: 5.377 - 5.448 5.448 - 5.503

Technical analysis

as of: 2021-03-05 8:42:41 AM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 8.39     One year: 9.88
Support: Support1: 5.12    Support2: 4.26
Resistance: Resistance1: 7.18    Resistance2: 8.46
Pivot: 6.44
Moving Average: MA(5): 5.84     MA(20): 6.59
MA(100): 16.10     MA(250): 24.87
MACD: MACD(12,26): -0.67     Signal(9): -0.74
Stochastic oscillator: %K(14,3): 7.72     %D(3): 10.24
RSI: RSI(14): 31.52
52-week: High: 41.12  Low: 4.66  Change(%): -85.0
Average Vol(K): 3-Month: 178162  10-Days: 76237

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
APRE has closed above bottom band by 5.7%. Bollinger Bands are 77.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to APRE's normal range. The bands have been in this narrow range for 31 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Tue, 23 Feb 2021
All You Need to Know About Aprea Therapeutics, Inc. (APRE) Rating Upgrade to Buy - Nasdaq

Tue, 16 Feb 2021
What Kind Of Shareholders Own Aprea Therapeutics, Inc. (NASDAQ:APRE)? - Simply Wall St

Thu, 11 Feb 2021
Aprea Therapeutics Inc (APRE) Up 8.47% in Premarket Trading - InvestorsObserver

Wed, 10 Feb 2021
Aprea Therapeutics Inc (APRE) Stock: How Does it Score? - InvestorsObserver

Thu, 04 Feb 2021
Aprea Therapeutics Inc (APRE) Up 6.40% in Premarket Trading - InvestorsObserver

Wed, 03 Feb 2021
Is it Time to Dump Aprea Therapeutics Inc (APRE) Stock After it Is Higher By 29.55% in a Week? - InvestorsObserver

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 21
Shares Float (M) 10
% Held by Insiders 12.91
% Held by Institutions 87.80
Shares Short (K) 1,050
Shares Short P. Month (K) 1,070

Stock Financials

EPS -26.670
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) -59.910
Profit Margin
Operating Margin
Return on Assets (ttm) -39.5
Return on Equity (ttm) -75.0
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -2.386
Qtrly Earnings Growth
Operating Cash Flow (M) -43
Levered Free Cash Flow (M) -20

Stock Valuations

PE Ratio -0.20
PEG Ratio
Price to Book value -0.09
Price to Sales
Price to Cash Flow -2.66

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.